Industry News
Diagnostic Digest: Two New Respiratory Assays, Testing For Enzymes; & More
Read this edition of the Diagnostic Digest to find out more about Roche's new respiratory test, enzymatic testing ...
OCTOBER 9, 2025
Generic Access to Lenacapavir Will Save Millions in Low-Income Countries
Millions more people at risk for HIV in low- and middle-income countries will have access to a low-cost generic ...
OCTOBER 1, 2025
Diagnostic Digest
Breakthrough Device Designation for Fungitell; new data on the BioFire Respiratory Panel; the cobas ePlex GI panel ...
SEPTEMBER 16, 2025
Sandoz Recalls 2nd Lot of Cefazolin Because of Mispackaging
A second lot of cefazolin was recalled due to mislabeling.
JULY 2, 2025
Sanofi Accelerates Beyfortus Shipping Ahead of Next RSV Season
Sanofi said it would ship nirsevimab starting earlier to ensure broad availability well ahead of the 2025-2026 RSV ...
JUNE 9, 2025
New Test Launches to Detect Respiratory Pathogens in Wastewater
A new option will be available soon to test wastewater for potential infectious respiratory disease ...
APRIL 22, 2025
Endotoxin Assay Moves From the Beach to the Bench
“Save the horseshoe crab!” may not stir the same public fervor as campaigns to preserve other more ...
FEBRUARY 12, 2025
FDA Accepts BLA for Clesrovimab to Protect Infants From RSV Disease
The FDA accepted the biologics license application for clesrovimab (MK-1654), Merck’s investigational, ...
JANUARY 13, 2025
FDA Grants Breakthrough Device Designation to New Sepsis Test
The FDA has granted Breakthrough Device designation to a new rapid diagnostic blood test for sepsis (MeMed ...
DECEMBER 10, 2024
Conserving IV Fluids Critical as Hurricane Flooding Damages Key Facility
One of the issues to deal with in the aftermath of Hurricane Helene is the possible shortage of IV fluids; no ...
OCTOBER 9, 2024
Atovaquone Oral Suspension Recalled Due to Bacterial Contamination
Atovaquone is a quinone antimicrobial drug indicated to prevent Pneumocystis jirovecii pneumonia. A single batch ...
SEPTEMBER 20, 2024
Karius Secures BARDA Contract to Expand Detection of Pathogens
Karius received a contract from the Division of Research, Innovation, and Ventures (DRIVe), under the BARDA, valued ...
AUGUST 12, 2024
